Medexus Pharmaceuticals Inc. (OTCMKTS:MEDXF – Get Free Report) shares fell 0.9% during trading on Wednesday . The stock traded as low as $3.60 and last traded at $3.61. Approximately 2,900 shares traded hands during mid-day trading, a decline of 78% from the average daily volume of 13,387 shares. The stock had previously closed at $3.6440.
Medexus Pharmaceuticals Stock Performance
The company has a 50 day simple moving average of $3.04 and a two-hundred day simple moving average of $2.57.
Medexus Pharmaceuticals Company Profile
Medexus Pharmaceuticals, Inc is a specialty pharmaceutical company headquartered in Mississauga, Ontario. The company focuses on acquiring, developing and commercializing niche prescription drug products for markets in Canada and the United States. Its efforts are aimed at underserved therapeutic areas, including rare diseases, oncology, hematology and dermatology.
Through strategic licensing and partnership agreements with international pharmaceutical firms, Medexus sources late‐stage and marketed assets, then manages their regulatory approval and commercialization.
Further Reading
- Five stocks we like better than Medexus Pharmaceuticals
- Why Johnson & Johnson’s Earnings Dip Looks Like a Buying Opportunity
- CPI Comes In Cool: Why It Could Revive These 3 Rate-Sensitive Stocks
- Why ASML’s AI Monopoly Is Still Getting Stronger
- Apple’s AI Toll Booth Thesis Faces Its Biggest Test Yet Before Earnings
Receive News & Ratings for Medexus Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medexus Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
